GlassScriptPhysician profile
Melissa S Clark
NPI 1639681000
$2,051.63
in general payments reported to CMS, 2019-2025
11 companies · $607 in 2025
The $607 reported for 2025 was more than what 77% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $255 · 2022: $359 · 2023: $303 · 2024: $528 · 2025: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,438.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius USA Marketing, INC. | $605.26 | 2021-2025 | Velphoro, Korsuva, Velphoro |
| Amgen INC. | $419.90 | 2021-2025 | Krystexxa, Parsabiv, Aranesp |
| Bayer Healthcare Pharmaceuticals INC. | $307.48 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $302.06 | 2021-2025 | Farxiga, Lokelma |
| Ardelyx, INC. | $187.51 | 2023-2025 | Xphozah 30 Mg, Ibsrela |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $123.07 | 2022 | |
| Horizon Therapeutics Plc | $37.73 | 2023 | Krystexxa |
| Mallinckrodt Hospital Products INC. | $31.36 | 2023 | Acthar |
| Otsuka America Pharmaceutical, INC. | $17.30 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.76 | 2025 | |
| Travere Therapeutics, INC. | $5.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.